主动脉瓣反流患者肺动脉高压的患病率及其对结局的影响
本研究基于澳大利亚国家超声心动图数据库(2000–2019年)的回顾性分析,纳入8392例LVEF>50%且存在中重度及以上主动脉瓣反流的成人。结果显示,仅16.9%无肺动脉高压,38.8%为临界性、26.9%为轻度、10.6%为中度、6.9%为重度肺动脉高压;校正年龄和性别后,eRVSP升高与长期死亡风险增加相关,从轻度肺动脉高压开始即存在死亡风险阈值。
要点
- 校正年龄和性别后,eRVSP升高与长期死亡风险增加相关,重度肺动脉高压aHR达3.32。
- 从轻度肺动脉高压(eRVSP 41.36–44.15 mm Hg)开始即出现死亡风险阈值(aHR 1.41)。
核心结论
- 在中重度及以上主动脉瓣反流患者中,肺动脉高压与进行性升高的死亡风险相关,即使在轻度升高水平也已存在风险。
研究设计与样本
- 回顾性研究,分析澳大利亚国家超声心动图数据库2000至2019年数据。
- 纳入8392例LVEF>50%且存在中重度及以上主动脉瓣反流的成人,按eRVSP分类,中位随访3.1年(IQR 1.5–5.7年)。
主要发现
- 患者年龄74±14岁,女性占58.4%(4901例)。
- 无肺动脉高压1417例(16.9%),临界性3253例(38.8%),轻度2249例(26.9%),中度893例(10.6%),重度580例(6.9%)。
- 女性平均eRVSP略高于男性(41±13 vs 39±12 mm Hg,p<0.0001),两性中eRVSP均随年龄增长而升高。
- 校正年龄和性别后,长期死亡风险随eRVSP升高而增加:临界性肺动脉高压aHR 1.20(95%CI 1.06–1.36),重度肺动脉高压aHR 3.32(95%CI 2.85–3.86),p<0.0001。
- 从轻度肺动脉高压开始存在死亡风险阈值(eRVSP 41.36–44.15 mm Hg;aHR 1.41,95%CI 1.17–1.68)。
临床怎么用
- 对中重度及以上主动脉瓣反流患者应评估肺动脉高压,即使轻度eRVSP升高也提示死亡风险增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Aortic regurgitation (AR) can lead to pulmonary hypertension (PHT). There is a paucity of data on the prognostic importance of PHT in these patients. We therefore aimed to describe the prevalence and prognostic importance of PHT in such patients. METHODS: In this retrospective study, we analysed the National Echocardiography Database of Australia (data from 2000 to 2019). Adults with an estimated right ventricular systolic pressure (eRVSP), left ventricular ejection fraction (LVEF) >50% and with moderate or greater AR were included (n=8392). These subjects were then categorised according to their eRVSP. The relationship between PHT severity and mortality outcomes were evaluated (median follow-up of 3.1 years, IQR 1.5-5.7 years). RESULTS: Subjects were aged 74±14 years and 58.4% (4901) were female. Overall, 1417 (16.9%) had no PHT, and 3253 (38.8%), 2249 (26.9%), 893 (10.6%) and 580 (6.9%) patients had borderline, mild, moderate and severe PHT, respectively. Mean eRVSP was slightly higher in females than males (41±13 vs 39±12 mm Hg, p<0.0001) and increased with age in both sexes. After adjustment for age and sex, the risk of long-term mortality increased as eRVSP increased (adjusted HR (aHR) 1.20, 95% CI 1.06 to 1.36 in borderline PHT, to aHR 3.32, 95% CI 2.85 to 3.86 in severe PHT, p<0.0001). There was a mortality threshold seen from mild PHT onwards (eRVSP 41.36-44.15 mm Hg; aHR 1.41, 95%CI 1.17 to 1.68). CONCLUSIONS: In this large cohort study, we characterise the relationship between AR and PHT in adults. In patients with ≥moderate AR, PHT is associated with a progressive risk of mortality, even at mildly elevated levels.
引用
- Ratwatte S, Playford D, Stewart S, et al. Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes. Heart. 2023. PMID: 37012044. doi:10.1136/heartjnl-2022-322187
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。